Living Donor Protection Act of 2025
- Sponsor
- Rep. Bacon, Don [R-NE-2]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 22, 2025
Bottom line
The bill aims to remove insurance barriers for living organ donors and improve public awareness of donation benefits and protections.
What it actually does
This bill prohibits life, disability, and long-term care insurance providers from discriminating against individuals solely because they are living organ donors, unless there are actual, unique, and material actuarial risks. It also mandates the Secretary of Health and Human Services to update educational materials on living organ donation, including information on these new insurance protections.
Proponents argue
Supporters argue that living organ donors perform a selfless act that saves lives and should not face financial penalties or discrimination in accessing essential insurance coverage. They contend that this bill removes a significant disincentive for potential donors and ensures they are not unfairly penalized for their generosity, thereby promoting organ donation.
Opponents contend
Critics might argue that while the intent is laudable, restricting insurers' ability to assess and price risk, even for a specific group, could set a precedent or potentially impact the broader insurance market. They may also raise concerns about the interpretation of 'actual, unique, and material actuarial risks' and the potential for increased litigation or regulatory burden.
The bill is very short and clear, making it highly accessible for a quick and thorough understanding.
Section 2(a)
Prohibition on Insurance Discrimination
This provision forbids insurance companies from denying coverage, canceling policies, refusing to issue new policies, or increasing premiums for life, disability, or long-term care insurance solely because an individual has donated an organ. An exception is made if there are specific, demonstrable, and significant actuarial risks associated with the individual's donation status.
Supporters argue
Supporters argue this provision is crucial for protecting the financial well-being of living organ donors, ensuring their altruistic act does not lead to unforeseen financial burdens or barriers to future insurance. This protection encourages more individuals to consider living organ donation.
Critics contend
Some insurers or industry groups might argue that the 'actual, unique, and material actuarial risks' clause could be challenging to interpret and apply consistently, potentially leading to disputes and increased regulatory scrutiny. They might also contend that any restriction on risk assessment could subtly impact pricing models.
Tradeoffs
The provision balances the protection of living organ donors with the need for insurers to maintain actuarial soundness. The tension lies in defining and proving 'actual, unique, and material actuarial risks' without undermining the core protection.
Section 3
Updating Educational Materials on Living Organ Donation
This section directs the Secretary of Health and Human Services (HHS) to review and update public educational materials related to living organ donation within six months of the bill's enactment. The updated materials must inform the public about the benefits and risks of donation, as well as the impact of donation on access to insurance, specifically including the new protections established by Section 2.
The prohibition on insurance discrimination includes a crucial carve-out: insurers can still deny coverage or increase premiums if there are 'actual, unique, and material actuarial risks' based on the person's status as a living organ donor.
Section 2(a)
Why it matters:This is standard legislative practice to provide necessary flexibility and prevent unintended consequences, allowing for legitimate risk assessment while still providing broad protection.
Case for: Supporters of this carve-out argue it ensures the financial stability of insurance markets by allowing insurers to account for genuine, data-driven risks, preventing the bill from inadvertently creating unsustainable insurance products.
Case against: Critics might argue that this clause could become a loophole, allowing insurers to broadly interpret 'actual, unique, and material actuarial risks' in a way that undermines the bill's intended protections for living organ donors.
Estimated impact: This clause will significantly influence the practical application and effectiveness of the anti-discrimination measure, determining how many donors ultimately receive protection versus those deemed to pose legitimate actuarial risks.
Enforcement of the insurance discrimination prohibition is delegated to State insurance regulators.
Section 2(b)
Why it matters:This is standard legislative practice for insurance regulation, which is primarily handled at the state level, rather than federal preemption.
Case for: Proponents argue that state regulators are best positioned to enforce insurance laws, as they have existing infrastructure, expertise, and relationships with local insurance markets and consumers.
Case against: Critics might contend that relying on state-level enforcement could lead to a patchwork of protections, with varying degrees of enforcement and interpretation across different states, potentially creating inequities for living organ donors depending on their residency.
Estimated impact: The effectiveness and uniformity of the bill's insurance protections will largely depend on the commitment and consistency of enforcement by individual state insurance regulators.